Friday, April 3, 2026
30.4 C
Bengaluru

Crafting a Digital Strategy

[wpfilebase tag=file id=104 tpl=download-button /]

Inside this Issue

1. Crafting a Digital Strategy: A Primer for Indian Pharma by  Manish Bajaj

Steps and mantras for digital transformation of the pharma organization

2. Effective Management begins with Role Clarity by K. Hariram

Role clarity and the importance of coaching for successful frontline management 

3. Digital Transformation in Pharma Begins with a Mindset Change by Sandeep Narula

The biggest challenge is not technology adoption but mindset change

4. Who Moved my Visual Aid?  by Vivek Hattangadi

A story of how digital technology made the Visual Aid obsolete – inspired by Dr. Spencer Johnson. Download here.

5. AIOCD Market Highlights  by Ameesh Masurekar

Market highlights for the month of January 2018

Download the issue here: PDF

Hot this week

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India

How the 2026 U.S. tariff action on branded drugs...

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Topics

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

As over 50 generic versions of the blockbuster weight-loss...
spot_img

Related Articles

spot_imgspot_img